Fármacos para control de la frecuencia ventricular y fármacos no-antiarrítmicos en fibrilación auricular / Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation
Arch. cardiol. Méx
;
77(supl.2): S2-54-S2-58, abr.-jun. 2007. ilus, tab
Article
in Spanish
| LILACS
| ID: lil-568849
ABSTRACT
Multiple drugs are helpful for rate control in different tachyarrhythmias, in particular atrial fibrillation (AF). Betablockers (betaB) and calcium channel blockers have been used as monotherapy or as adjunctive therapy to antiarrhythmics for mantaining an acceptable ventricular rate. In recent years new concepts about auricular remodelation process as a consequence of AF has shown benefits with drugs as angiotensin-renin system blockers (ARSB) like angiotensin conversing enzime inhibitors (ACEI) and angiotensin receptor blockers (ARB). In this article it will be reviewed the benefits of rate control in AF by using betaB and calcium channel blockers and also the benefits in atrial remodelation process and the prevention of AF with ARSB drugs.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Atrial Fibrillation
/
Calcium Channel Blockers
/
Adrenergic beta-Antagonists
/
Angiotensin II Type 1 Receptor Blockers
/
Anti-Arrhythmia Agents
Type of study:
Controlled clinical trial
/
Systematic reviews
Limits:
Humans
Language:
Spanish
Journal:
Arch. cardiol. Méx
Journal subject:
Cardiology
Year:
2007
Type:
Article
Affiliation country:
Mexico
Institution/Affiliation country:
Instituto Nacional de Cardiología Ignacio Chávez/MX
Similar
MEDLINE
...
LILACS
LIS